PRF Technologies Issues Letter to Shareholders Highlighting Financial Position and Strategic Progress

In a letter to shareholders dated October 23, 2026, PRF Technologies Ltd. Interim CEO Efraim Cohen-Arazi announced the company raised approximately $10.5 million through an equity line facility in the first nine months of 2026. As of September 30, 2026, PRF Technologies reported $11.0 million in cash and short-term deposits against total liabilities of $2.5 million. The company is progressing with its pharmaceutical division, particularly with the upcoming Phase 2 clinical trial for its OcuRing™-K product, and is developing the GridFeed™ platform for AI-driven energy optimization in data centers.